A window on the current status of diabetes mellitus in Singapore - The diabcare - Singapore 1998 study

Singapore Medical Journal

Volumn 42, Issue 11, 2001, Pages 501-507

  Lee, Warren ^b   Lim, H S ^b   Thai, A C ^b   Chew, W L S ^b   Emmanuel, S ^a   Goh, L G ^b   Lau, H C ^b   Lee, C H ^b   Soon, P C ^b   Tambyah, J A ^b   Tan, Y T ^b   Jorgensen, L N ^b   Chua, A ^b   Yeo, J P ^b  

^a MINISTRY OF HEALTH   (Singapore)

^b NONE

Author keywords

Demographic profile; Diabetes mellitus; HbA1c; Metabolic control; Singapore

Indexed keywords

LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; SINGAPORE;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; SINGAPORE; TRIGLYCERIDES;

EID: 0035524683     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes Care 1998; 21 Suppl 1:S88-S90.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33). Lancet 1998; 352:837-53.
3. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. (UKPDS 34). Lancet 1998; 352: 854-65.
4. Cockram C. Diabetes management in Asia. International Diabetes Monitor 1999; April: 11-6.
5. Mustaffa BE, Mohamad WB, Chan SP, Rokiah P, Mafauzy M, Kumari S, Chandran AA, Ong GKC, Jorgensen LN and Yeo JP. The current status of diabetes management in Malaysia. JAFES 1998; 16:1-13.
6. Kapur A, Jorgensen LN, Ramamoorthy S, Yeo JP, Pendsey S, Sahay BK, et al. Diabetes care in India - Current status. J Assoc Physicians India. In press.
7. WHO. Hypertension control: report of a WHO expert committee. WHO Technical Report Series 862, Geneva, World Health Organisation, 1996.
8. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997; 20 Suppl 1: S5-S13.
9. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM). A contribution to the implementation of the St. Vincent Declaration, 1993.
10. Non-insulin dependent diabetes mellitus (NIDDM) practical targets and treatments. Asia-Pacific NIDDM Policy Group, 1995.
11. Ministry of Health. Clinical practice guidelines - diabetes mellitus, 1999.
12. Cheah JS, Lui KF, Yeo PPB, Tan YT, Ng YK. Diabetes mellitus in Singapore, results of a country-wide population survey. In: Cheah JS ed. Proceedings of the 6th Asian and Oceania Congress of Endocrinology, 1978; 227-38.
13. Epidemiology and disease control department. In: National Health Survey 1998. Ministry of Health, 1999; 5-9.
14. Zimmet P, McCarty DJ and Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. Diabetes Care 1997; 11:60-8.
15. Harris MI. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 2000; 6:754-8.
16. American diabetes association. Diabetic nephropathy. Diabetes Care 1998: 21 Suppl 1:S50-S53.
17. Thai AC, Yeo PPB, Lun KC, Hughes K, Ng WY, Lui KF, Cheah JS. Diabetes mellitus and its chronic complications in Singapore: an increasing healthcare problem. Ann Acad Med Singapore 1990; 19(4):517-23.
18. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG. and Pecoraro RF. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995; 18:216-9.
19. Reiber GE, Pecoraro RE, and Koepsell TD. Risk factors for amputation in patients with diabetes mellitus. Ann Intern Med 1992; 117:97-105.
20. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993; 329:977-86.
21. The Diabetes Control and Complications Trial Research Group. Prevention of neuropathy: the effect of intensive diabetes therapy on the development and progression of neuropathy in the DCCT. Ann Intern Med 1995; 122:564-8.
22. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on the development of diabetic nephropathy in the DCCT. Kidney Int 1995; 47:1703-20.